Department of Oral Biology, SUNY at Buffalo, 3435 Main St., Buffalo, NY 14214-3092, USA.
Infect Immun. 2011 Mar;79(3):1270-9. doi: 10.1128/IAI.00871-10. Epub 2010 Dec 20.
The genome of Borrelia burgdorferi, the Lyme disease spirochete, encodes a homolog (the bb0184 gene product) of the carbon storage regulator A protein (CsrA(Bb)); recent studies reported that CsrA(Bb) is involved in the regulation of several infectivity factors of B. burgdorferi. However, the mechanism involved remains unknown. In this report, a csrA(Bb) mutant was constructed and complemented in an infectious B31A3 strain. Subsequent animal studies showed that the mutant failed to establish an infection in mice, highlighting that CsrA(Bb) is required for the infectivity of B. burgdorferi. Western blot analyses revealed that the virulence-associated factors OspC, DbpB, and DbpA were attenuated in the csrA(Bb) mutant. The Rrp2-RpoN-RpoS pathway (σ(54)-σ(S) sigma factor cascade) is a central regulon that governs the expression of ospC, dbpB, and dbpA. Further analyses found that the level of RpoS was significantly decreased in the mutant, while the level of Rrp2 remained unchanged. A recent study reported that the overexpression of BB0589, a phosphate acetyl-transferase (Pta) that converts acetyl-phosphate to acetyl-coenzyme A (CoA), led to the inhibition of RpoS and OspC expression, suggesting that acetyl-phosphate is an activator of Rrp2. Along with this report, we found that CsrA(Bb) binds to the leader sequence of the bb0589 transcript and that the intracellular level of acetyl-CoA in the csrA(Bb) mutant was significantly increased compared to that of the wild type, suggesting that more acetyl-phosphate was being converted to acetyl-CoA in the mutant. Collectively, these results suggest that CsrA(Bb) may influence the infectivity of B. burgdorferi via regulation of acetate metabolism and subsequent activation of the Rrp2-RpoN-RpoS pathway.
伯氏疏螺旋体(Borrelia burgdorferi)的基因组编码了碳储存调控蛋白 A 同源物(bb0184 基因产物);最近的研究报道称,CsrA(Bb)参与了伯氏疏螺旋体的几种感染因子的调节。然而,涉及的机制仍不清楚。在本报告中,构建了一个 csrA(Bb)突变体,并在感染性 B31A3 株中进行了互补。随后的动物研究表明,该突变体不能在小鼠中建立感染,这突出表明 CsrA(Bb)是伯氏疏螺旋体感染所必需的。Western blot 分析显示,毒力相关因子 OspC、DbpB 和 DbpA 在 csrA(Bb)突变体中减弱。Rrp2-RpoN-RpoS 途径(σ(54)-σ(S)sigma 因子级联)是一个中央调控子,负责 ospC、dbpB 和 dbpA 的表达。进一步的分析发现,突变体中 RpoS 的水平显著降低,而 Rrp2 的水平保持不变。最近的一项研究报告称,磷酸乙酰转移酶(Pta)BB0589 的过表达会抑制 RpoS 和 OspC 的表达,该酶将乙酰磷酸转化为乙酰辅酶 A(CoA),这表明乙酰磷酸是 Rrp2 的激活剂。结合本报告,我们发现 CsrA(Bb)结合到 bb0589 转录物的前导序列上,并且 csrA(Bb)突变体中的细胞内乙酰辅酶 A 水平与野生型相比显著增加,这表明突变体中更多的乙酰磷酸转化为乙酰辅酶 A。总的来说,这些结果表明,CsrA(Bb)可能通过调节乙酸代谢并随后激活 Rrp2-RpoN-RpoS 途径来影响伯氏疏螺旋体的感染力。